This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
BXP's Q3 FFO Meets Estimates, Lease Revenues Increase Y/Y
by Zacks Equity Research
BXP's Q3 FFO per share matches estimates. Results reflect higher revenues amid healthy leasing activity. However, high interest expenses hurt.
Alexandria Q3 AFFO Misses Estimates, Revenues Increase Y/Y
by Zacks Equity Research
ARE's Q3 results reflect a year-over-year rise in revenues, backed by decent leasing activity and higher rental rates.
Compared to Estimates, Alexandria Real Estate Equities (ARE) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Alexandria Real Estate Equities (ARE) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alexandria Real Estate Equities (ARE) Q3 FFO Miss Estimates
by Zacks Equity Research
Alexandria Real Estate Equities (ARE) delivered FFO and revenue surprises of -0.42% and 2.02%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Crown Castle's Q3 AFFO Top Estimates, Site-Rental Revenues Rise
by Zacks Equity Research
CCI's Q3 AFFO outshines estimates due to a year-over-year rise in site rental revenues. However, lower services and other revenues hurt the results.
Crown Castle's Q3 AFFO Beats Estimates, Expenses Decrease Y/Y
by Zacks Equity Research
CCI's Q3 AFFO tops estimates. Results reflect higher contributions from site rental revenues and lower operating expenses.
Alexandria to Post Q3 Earnings: What's in the Cards for the Stock?
by Zacks Equity Research
While ARE's Q3 earnings are likely to have gained from healthy demand for its high-quality life science and lab office properties, high interest expenses are a concern.
What Analyst Projections for Key Metrics Reveal About Alexandria Real Estate Equities (ARE) Q3 Earnings
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Alexandria Real Estate Equities (ARE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
Here's Why You Should Retain Alexandria Stock in Your Portfolio Now
by Zacks Equity Research
ARE should gain from the solid demand for top-quality life science assets in key markets, though a vast development outlay raises the risks of cost overruns.
Top Research Reports for Broadcom, Novo Nordisk & ConocoPhillips
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Novo Nordisk A/S (NVO) and ConocoPhillips (COP), as well as two micro-cap stocks Smith-Midland Corp. (SMID) and Tredegar Corp. (TG).
Implied Volatility Surging for Alexandria (ARE) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Alexandria (ARE) stock based on the movements in the options market lately.
Alexandria Sells Asset to Redeploy in Development, Redevelopment Moves
by Zacks Equity Research
Keeping up with its capital-recycling strategy, Alexandria announces the completion of the sale of 1165 Eastlake Avenue East for $150 million.
BXP's Q2 FFO Outpaces Estimates, Lease Revenues Rise Y/Y
by Zacks Equity Research
BXP's Q2 results beat estimates on better-than-anticipated revenues, aided by healthy leasing activity. It has raised the 2024 FFO per share guidance.
Healthpeak's (DOC) Q2 FFO Beat Estimates, Same-Store NOI Up
by Zacks Equity Research
Healthpeak's (DOC) Q2 results outshine estimates on better-than-anticipated revenues. Total merger-combined same-store cash NOI improves year over year. It has revised its 2024 outlook.
Company News for Jul 24, 2024
by Zacks Equity Research
Companies in The News Are: DHR, GM, PM, ARE
Alexandria (ARE) Q2 AFFO Beats Estimates, Revenues Miss
by Zacks Equity Research
Alexandria's (ARE) Q2 AFFO outshines estimates. Results reflect decent leasing activity and higher rental rates.
Alexandria Real Estate Equities (ARE) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Alexandria Real Estate Equities (ARE) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alexandria Real Estate Equities (ARE) Surpasses Q2 FFO Estimates
by Zacks Equity Research
Alexandria Real Estate Equities (ARE) delivered FFO and revenue surprises of 0.85% and 1.23%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Alexandria (ARE) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
While Alexandria's (ARE) Q2 earnings are likely to have benefited from the healthy demand for its high-quality life science and lab office properties, high interest expenses raise concerns.
Why Alexandria Real Estate Equities (ARE) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Welltower's (WELL) Stock Rises 18.1% YTD: Will the Trend Last?
by Zacks Equity Research
Welltower (WELL) is likely to gain from a rise in healthcare spending by senior citizens and capital recycling activities. However, a high interest rate environment adds to its woes.
Highwoods (HIW) Stock Rises 13.1% Year to Date: Here's How
by Zacks Equity Research
A Sun Belt focused portfolio and disciplined capital-recycling strategy bode well for Highwoods (HIW). However, competition from peers and high interest rates add to its woes.
SL Green (SLG) Stock Rises 24.9% Year to Date: Here's How
by Zacks Equity Research
Healthy demand for premier office properties and a diverse tenant base are likely to support SL Green (SLG). However, an elevated supply of office spaces and high interest rates remain concerns.
Ventas (VTR) Hits 52-Week High: Will the Stock Trend Higher?
by Zacks Equity Research
Ventas (VTR) is expected to continue to benefiting from a favorable senior housing operating portfolio and outpatient visit trends.